These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24131838)

  • 21. [Urticaria in relation to mite sensitivity and immunotherapy with Injection dermatophagoidei farinae].
    Xing DR; Wen TH; Yu YL; Wei ZP; Li YM; Han T
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):422-7. PubMed ID: 19288915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the efficacy of immunotherapy with a glutaraldehyde-modified house dust mite extract in children by monitoring changes in clinical parameters and inflammatory markers in exhaled breath.
    Lozano J; Cruz MJ; Piquer M; Giner MT; Plaza AM
    Int Arch Allergy Immunol; 2014; 165(2):140-7. PubMed ID: 25471080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period.
    Nuhoglu Y; Ozumut SS; Ozdemir C; Ozdemir M; Nuhoglu C; Erguven M
    J Investig Allergol Clin Immunol; 2007; 17(6):375-8. PubMed ID: 18088019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
    Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
    J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the efficacy and safety of standardized dust mite allergen specific immunotherapy to children with allergic asthma].
    Song W; Lin X; Xie H; Chai R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1193-6. PubMed ID: 24617000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy.
    Stelmach I; Sobocińska A; Majak P; Smejda K; Jerzyńska J; Stelmach W
    Ann Allergy Asthma Immunol; 2012 Oct; 109(4):274-8. PubMed ID: 23010234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study of asthma desensitization in 1182 children, 592 asthmatic children and 590 nonatopic controls.
    Cantani A; Micera M
    Eur Rev Med Pharmacol Sci; 2005; 9(6):325-9. PubMed ID: 16479736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
    Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
    Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of specific immunotherapy for patients allergic to house-dust mites and pollen in relation to the development of neoplasia and autoimmune disease: a long-term, observational case-control study.
    Bozek A; Kozłowska R; Jarzab J
    Int Arch Allergy Immunol; 2014; 163(4):307-12. PubMed ID: 24776522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
    Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy.
    Bronnert M; Mancini J; Birnbaum J; Agabriel C; Liabeuf V; Porri F; Cleach I; Fabre A; Deneux I; Grandné V; Grob JJ; Berbis P; Charpin D; Bongrand P; Vitte J
    Clin Exp Allergy; 2012 Sep; 42(9):1406-15). PubMed ID: 22747483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serious systemic adverse events associated with allergen-specific immunotherapy in children with asthma].
    Dai L; Huang Y; Wang Y; Han HL; Li QB; Jiang YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):58-61. PubMed ID: 24461180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of Dermatophagoides pteronyssinus allergen-specific immunotherapy on the prognosis of asthmatic children].
    Chen ZG; Chen YF; Li M; Ji JZ; Chen FH; Chen H
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1179-81. PubMed ID: 19726355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of CD4+CD25+Foxp3+IL-10+ T cells in HDM-allergic asthmatic children with or without SIT.
    Wei W; Liu Y; Wang Y; Zhao Y; He J; Li X; Shen K
    Int Arch Allergy Immunol; 2010; 153(1):19-26. PubMed ID: 20357481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children.
    Chen ZG; Li M; Chen YF; Ji JZ; Li YT; Chen W; Chen FH; Chen H
    Chin Med J (Engl); 2009 May; 122(10):1157-61. PubMed ID: 19493463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of mite allergen immunotherapy on the altered phenotype of dendritic cells in allergic asthmatic children.
    Wang CM; Chuang JJ
    Ann Allergy Asthma Immunol; 2013 Feb; 110(2):107-12. PubMed ID: 23352530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation of serum eosinophil cationic protein with the severity of allergic rhinitis in childhood].
    Zhu XJ; Lu MP; Chen RX; Zhu LP; Qi QH; Yin M; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):628-32. PubMed ID: 23141391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.